Integrating Psychological and Pharmacological Treatments for Addictive Disorders
69,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
  • Broschiertes Buch

Integrating Psychological and Pharmacological Treatments for Addictive Disorders distills the complex literature on addiction, offering a curated toolbox of integrated pharmacological and psychotherapeutic treatments in chapters authored by leading experts. Introductory chapters on the epidemiology, etiology, and fundamentals of addiction treatment provide a concise overview of the state of the field. Subsequent chapters then focus on the treatment of specific substance use disorders and on gambling disorder. Finally, a chapter on the treatment of addiction in primary care addresses the…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Integrating Psychological and Pharmacological Treatments for Addictive Disorders distills the complex literature on addiction, offering a curated toolbox of integrated pharmacological and psychotherapeutic treatments in chapters authored by leading experts. Introductory chapters on the epidemiology, etiology, and fundamentals of addiction treatment provide a concise overview of the state of the field. Subsequent chapters then focus on the treatment of specific substance use disorders and on gambling disorder. Finally, a chapter on the treatment of addiction in primary care addresses the opportunities for clinical care in non-specialist outpatient settings. Physicians, psychologists, social workers, and other mental health professionals will come away from the book with an essential understanding of evidence-based practice in treating addiction and the scientific foundations of those approaches. .
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
James MacKillop, PhD, is the Peter Boris Chair in Addictions Research and director of the Peter Boris Center for Addictions Research at McMaster University/St. Joseph's Healthcare Hamilton. He is also a senior scientist at the Homewood Research Institute and holds courtesy faculty appointments at the University of Georgia and Brown University. He conducts translational research using basic behavioral science, cognitive neuroscience, behavioral genetics, and clinical science to advance the understanding and treatment of addiction. George A. Kenna, PhD, RPh, is an assistant professor of psychiatry (research) at Brown University, where he performs clinical trials for the treatment of alcohol use disorder. He is a clinical pharmacist at Westerly Hospital, Westerly, Rhode Island, and is also an adjunct assistant professor at the University of Rhode Island. Lorenzo Leggio, MD, PhD, MSc, is a physician-scientist who conducts clinical research on medication development and the role of neuroendocrine signaling in addictions. His clinical and research training took place between the Catholic University of Rome and Brown University. Throughout his career, he has worked at Brown University and the National Institutes of Health. Lara A. Ray, PhD, is a professor of psychology, co-director of the Addiction and Behavioral Medicine Clinic, and a faculty member in the department of psychiatry and biobehavioral sciences and Brain Research Institute at the University of California, Los Angeles.